Insurance Communication Prompt Templates

PRIOR AUTHORIZATION REQUEST

Date: [Today]
Patient: [Name], DOB: [Date]
Member ID: [Number]
Provider: [Your name and NPI]

Medication Requested: Adalimumab (Humira) 40mg subcutaneous every 2 weeks

Diagnosis: Rheumatoid arthritis, moderate-to-severe (ICD-10: M05.79)

Clinical Summary:

Ms. [Name] is a 34-year-old woman with rheumatoid arthritis diagnosed 18 months ago. Despite appropriate conventional DMARD therapy, she has progressive disease with ongoing joint inflammation and early erosive changes on imaging.

Current Disease Activity:
• Active joint count: 12 swollen joints, 14 tender joints
• DAS28 score: 5.8 (high disease activity)
• CRP: 2.4 mg/dL (elevated)
• Recent X-rays: New erosions in MCP joints bilaterally

Treatment History:

1. Methotrexate 25mg weekly x 6 months
 Result: Inadequate response. Continued high disease activity despite dose optimization and 6 months of therapy.

2. Sulfasalazine 2g daily (attempted)
 Result: Discontinued after 3 weeks due to significant GI intolerance (nausea, diarrhea) despite dose titration.

3. Current: Methotrexate 25mg weekly + prednisone 7.5mg daily
 Result: Requiring ongoing corticosteroids to partially control symptoms. This is not a sustainable long-term strategy.

Clinical Rationale:

Per American College of Rheumatology guidelines, patients with moderate-to-severe RA who have inadequate response to DMARD monotherapy should be treated with a biologic DMARD. Ms. [Name] meets this criterion, having failed methotrexate at therapeutic doses for adequate duration and being unable to tolerate sulfasalazine.

Also:
• She has poor prognostic factors: high disease activity, elevated inflammatory markers, early erosive disease
• Continued disease activity leads to irreversible joint destruction
• Delay in effective therapy increases disability risk

Consequences of Denial:

Without biologic therapy, this patient faces:
• Progressive joint erosion and deformity
• Long-term corticosteroid dependence with associated complications
• Increasing functional disability
• Likely need for joint replacement surgery at a young age
• Loss of work capacity (she is currently employed)

I am requesting authorization for adalimumab as the next appropriate step in her treatment per evidence-based guidelines.

Please contact me with any questions.

[Your name, credentials]
[Contact information]
[NPI]

APPEAL: MRI Lumbar Spine - Denial Overturned Requested

Date: [Today]
Patient: [Name], DOB: [Date]
Member ID: [Number]
Claim/Reference Number: [Number]
Date of Denial: [Date]

Dear Medical Director,

I am writing to appeal the denial of MRI lumbar spine for my patient, [Name]. The denial letter cited 'conservative therapy not documented.' This information was included in the original request, and I am resubmitting with additional clarification and new supporting evidence.

Request: MRI lumbar spine without contrast

Clinical Situation:

Mr. [Name] is a 58-year-old man with 8 weeks of severe left leg pain radiating from the buttock to the lateral calf and foot, consistent with L5 radiculopathy. He has not responded to conservative management and has progressive neurological findings.

Conservative Therapy Completed:

1. Physical therapy: 6 weeks, 12 sessions (documentation attached)
 Result: No significant improvement. Continues to rate pain 8/10.

2. NSAIDs: Naproxen 500mg twice daily x 6 weeks
 Result: Minimal relief. Unable to increase dose due to GI symptoms.

3. Activity modification and home exercises: Ongoing
 Result: Limited by pain severity.

Progressive Neurological Findings:

• Left foot drop (4/5 ankle dorsiflexion) - new since initial presentation
• Diminished sensation in L5 dermatome
• Positive straight leg raise at 30 degrees
• Nerve conduction study (performed [date]): Findings consistent with left L5 radiculopathy

Why MRI Is Medically Necessary:

Per ACR Appropriateness Criteria, MRI is indicated for lumbar radiculopathy when:
• Symptoms persist beyond 6 weeks of conservative therapy (met)
• Progressive neurological deficit is present (met - new foot drop)
• Surgical intervention is being considered (patient is surgical candidate if imaging confirms structural cause)

This patient meets all criteria. Imaging is necessary to:
1. Confirm the anatomical cause of radiculopathy
2. Determine if surgical decompression is indicated
3. Rule out other pathology

Consequences of Continued Delay:

The patient has developed foot drop, indicating motor nerve involvement. Prolonged nerve compression can result in permanent weakness. Timely imaging is essential to prevent irreversible neurological damage.

Documentation Enclosed:
• PT records (6 weeks, 12 visits)
• Office notes documenting medication trial
• Nerve conduction study report
• Physical examination findings

Requested Action:

I respectfully request that you overturn this denial and authorize MRI lumbar spine without contrast. If additional information is needed, please contact my office directly.

Thank you for your reconsideration.

[Your name, credentials]
[Contact information]

LETTER OF MEDICAL NECESSITY
Continuous Glucose Monitoring System

Date: [Today]
Patient: [Name]
DOB: [Date]
Diagnosis: Type 1 Diabetes Mellitus (E10.65) with hypoglycemia unawareness

To Whom It May Concern:

I am writing to document the medical necessity of a continuous glucose monitoring (CGM) system for my patient, [Name], who has Type 1 diabetes with hypoglycemia unawareness and recurrent severe hypoglycemic episodes.

Clinical Background:

Mr./Ms. [Name] is a 28-year-old with Type 1 diabetes diagnosed at age 12. Despite diligent self-management, they have developed hypoglycemia unawareness, a dangerous condition in which the patient no longer perceives the warning symptoms of low blood sugar until it is critically low.

Current Management:
• Insulin regimen: Basal-bolus therapy (insulin glargine + insulin lispro)
• Monitoring: Fingerstick blood glucose 8-10 times daily
• A1C: 7.2% (at goal)
• Diabetes education: Completed, with carb counting proficiency

The Problem:

Despite frequent fingerstick monitoring and good overall glycemic control, this patient has experienced:

• 4 severe hypoglycemic episodes in the past 6 months requiring assistance from another person
• 2 episodes resulting in loss of consciousness
• 1 emergency department visit for hypoglycemia
• Documented hypoglycemia unawareness (does not sense blood glucose below 50 mg/dL)

Fingerstick monitoring, even at 8-10 times daily, only captures point-in-time values. It cannot detect rapid drops between checks, alert to impending hypoglycemia during sleep, or show glucose trends. This patient's dangerous lows are occurring overnight and between fingerstick checks.

Why CGM Is Medically Necessary:

Continuous glucose monitoring provides:

1. Real-time glucose values every 5 minutes
2. Trend arrows showing direction and rate of change
3. Customizable alarms for impending hypo/hyperglycemia
4. Overnight monitoring with alerts that wake the patient before dangerous lows

For patients with hypoglycemia unawareness, CGM is the standard of care. The American Diabetes Association and Endocrine Society guidelines recommend CGM for all patients with Type 1 diabetes, with particular emphasis on those with hypoglycemia unawareness.

Evidence:

Multiple randomized controlled trials (JDRF CGM Study, DIAMOND, HypoDE) demonstrate that CGM:
• Reduces severe hypoglycemia by 50-70%
• Reduces time in hypoglycemic range
• Improves or maintains A1C
• Is cost-effective compared to recurrent ER visits and hospitalizations

Consequences Without CGM:

Without CGM, this patient will continue to experience:
• Recurrent severe hypoglycemia with risk of seizure, coma, or death
• Inability to safely drive or live independently
• Risk of cardiac arrhythmia during hypoglycemia
• Ongoing emergency department visits and potential hospitalizations

Summary:

[Patient name] has Type 1 diabetes with documented hypoglycemia unawareness and recurrent severe hypoglycemia despite intensive fingerstick monitoring. CGM is medically necessary to prevent life-threatening hypoglycemic events and is consistent with evidence-based guidelines for this condition.

Please approve this request. I am available to discuss further if needed.

[Your name, credentials]
[Specialty]
[Contact information]

PEER-TO-PEER CALL PREP
Inpatient Rehabilitation vs. SNF - Hip Fracture

Patient Summary (30 seconds):
"This is a 72-year-old who was fully independent before a hip fracture. She underwent ORIF 3 days ago and now needs rehabilitation. She has a history of heart failure that requires monitoring during intensive therapy. Her goal is to return home independently."

The Denial:
Insurance says she can go to a skilled nursing facility instead of inpatient rehab.

Your Counter-Arguments:

1. Medical Complexity
"She has NYHA Class II heart failure. She needs cardiac monitoring during intensive physical therapy. A SNF cannot provide the level of medical oversight she requires."

2. Rehabilitation Intensity Needed
"To regain independence, she needs 3 hours of therapy daily. SNFs typically provide 1-1.5 hours. The intensity difference affects outcomes."

3. High Rehabilitation Potential
"She was living alone, driving, and managing all ADLs before this fracture. Her cognitive status is intact. She's an excellent rehab candidate who can return to independence with intensive therapy."

4. Evidence
"Studies show that hip fracture patients with medical comorbidities who receive inpatient rehabilitation have lower mortality, better functional outcomes, and are more likely to return home compared to SNF."

Key Criteria She Meets (InterQual/MCG for Inpatient Rehab):
□ Requires 24-hour rehabilitation nursing
□ Can tolerate 3 hours of therapy daily
□ Has medical condition requiring physician oversight (heart failure)
□ Has realistic goals for improvement
□ Requires multidisciplinary team (PT, OT, nursing, physician)

Anticipated Pushback and Responses:

"She can get therapy at a SNF."
→ "The intensity and medical oversight are not equivalent. She needs monitoring during exertion given her cardiac history."

"Her cardiac condition is stable."
→ "It's stable at rest. During intensive therapy with increased cardiac demand, she needs the monitoring that inpatient rehab provides."

"SNF is more cost-effective."
→ "If she declines at a SNF or has a cardiac event without proper monitoring, she'll end up readmitted. Inpatient rehab is the appropriate level of care to prevent complications."

Your Ask:
"I'm asking you to authorize inpatient rehabilitation admission for 7-10 days. She meets medical necessity criteria and has the potential to return home with this level of care."

Have Ready:
• Hospital notes
• Cardiology consult
• PT/OT evaluations
• Pre-injury functional status documentation